TIRZEPATIDE

181068 reported adverse events

Drug classes: GLP-1 Receptor Agonist [EPC] Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

These side effects are most commonly reported by patients taking TIRZEPATIDE:

# Side effect Count
0 INCORRECT DOSE ADMINISTERED 32155
1 NAUSEA 19738
2 INJECTION SITE PAIN 14616
3 DIARRHOEA 11312
4 EXTRA DOSE ADMINISTERED 10288
5 OFF LABEL USE 10041
6 VOMITING 9395
7 DRUG INEFFECTIVE 8287
8 CONSTIPATION 7625
9 FATIGUE 5698
See all common reactions for TIRZEPATIDE

TIRZEPATIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG TITRATION ISSUE 112 0.6120
1 INTERCEPTED PRODUCT SELECTION ERROR 606 0.4654
2 INJECTION SITE COLDNESS 316 0.3726
3 THERAPEUTIC RESPONSE CHANGED 2265 0.3571
4 INTERCEPTED PRODUCT DISPENSING ERROR 589 0.3550
5 ACCIDENTAL UNDERDOSE 4610 0.3200
6 STARVATION KETOACIDOSIS 59 0.2921
7 INJECTION SITE INJURY 1527 0.2751
8 PRODUCT TAMPERING 468 0.2604
9 EXTRA DOSE ADMINISTERED 10288 0.2537
See all enriched reactions for TIRZEPATIDE